METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC)
Clinical trials for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers track how long men stay on prostate cancer drugs
Knowledge-focused CompletedThis study looked back at real-world medical records to understand how long men with advanced prostate cancer that still responds to hormone therapy actually stay on two common medications: apalutamide and enzalutamide. Researchers analyzed data from about 1,300 men who were trea…
Matched conditions: METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC)
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Finnish study maps the Real-World journey of advanced prostate cancer
Knowledge-focused CompletedThis study looked back at the medical records of over 1,000 men in Finland with advanced prostate cancer that had spread. Its goal was to understand who gets this disease, what treatments they receive, and how well those treatments work in everyday practice. By analyzing this rea…
Matched conditions: METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC)
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC